- call +1-201-465-4211
- email sales@mrinsights.biz
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites. Infections thus caused can be classified depending on type of organism causing the infection and symptoms and medical signs shown by the host.
Scope of the Report:
This report focuses on the Anti-infective Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America was one of the dominated countries in 2015 with a revenue generation of over USD 26.3 billion. The presence of sophisticated healthcare infrastructure and high awareness amongst the end-users such as clinicians and healthcare professionals in this region are estimated to be the key factors contributing to this large share. Moreover, in this region, the high purchasing power of expensive drugs and the presence of favorablereimbursement policies are the drivers projected to accentuate the growth of the anti-infective agents market.
Asia-Pacific is expected to witness significant growth over the forecast period owing to the presence of generics companies, the rising economic stability, and the increasing level of disposable income. In addition, the growing geriatric population base coupled with the increased susceptibility to infections is expected to provide a potential growth platform to this industry.
The worldwide market for Anti-infective Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Pfizer Inc.
Abbott Laboratories
Gilead Sciences, Inc.
Bristol-Myers Squibb Co.
Merck & Co., Inc.
Bayer Healthcare AG
AstraZeneca Plc.
Boehringer Ingelheim
Novartis AG
Astellas Pharma, Inc.
GlaxoSmithKline Plc.
Alcon Pharmaceuticals Ltd.
Sanofi-Aventis S.A.
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Market Segment by Applications, can be divided into
Hospital Use
Clinic Use
Household
Other
There are 15 Chapters to deeply display the global Anti-infective Agents market.
Chapter 1, to describe Anti-infective Agents Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Anti-infective Agents, with sales, revenue, and price of Anti-infective Agents, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-infective Agents, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Anti-infective Agents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Anti-infective Agents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anti-infective Agents Introduction
1.2 Market Analysis by Type
1.2.1 Antibacterial Drugs
1.2.2 Antifungal Drugs
1.2.3 Antiviral Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital Use
1.3.2 Clinic Use
1.3.3 Household
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Business Overview
2.1.2 Anti-infective Agents Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 Anti-infective Agents Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Gilead Sciences, Inc.
2.3.1 Business Overview
2.3.2 Anti-infective Agents Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Gilead Sciences, Inc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb Co.
2.4.1 Business Overview
2.4.2 Anti-infective Agents Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Co. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck & Co., Inc.
2.5.1 Business Overview
2.5.2 Anti-infective Agents Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck & Co., Inc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bayer Healthcare AG
2.6.1 Business Overview
2.6.2 Anti-infective Agents Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Healthcare AG Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca Plc.
2.7.1 Business Overview
2.7.2 Anti-infective Agents Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca Plc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 Anti-infective Agents Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novartis AG
2.9.1 Business Overview
2.9.2 Anti-infective Agents Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis AG Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Astellas Pharma, Inc.
2.10.1 Business Overview
2.10.2 Anti-infective Agents Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Astellas Pharma, Inc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GlaxoSmithKline Plc.
2.11.1 Business Overview
2.11.2 Anti-infective Agents Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GlaxoSmithKline Plc. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Alcon Pharmaceuticals Ltd.
2.12.1 Business Overview
2.12.2 Anti-infective Agents Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Alcon Pharmaceuticals Ltd. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi-Aventis S.A.
2.13.1 Business Overview
2.13.2 Anti-infective Agents Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Sanofi-Aventis S.A. Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Johnson & Johnson
2.14.1 Business Overview
2.14.2 Anti-infective Agents Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Johnson & Johnson Anti-infective Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anti-infective Agents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Anti-infective Agents Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anti-infective Agents Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-infective Agents Manufacturer Market Share in 2017
3.3.2 Top 6 Anti-infective Agents Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Anti-infective Agents Market Analysis by Regions
4.1 Global Anti-infective Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-infective Agents Sales and Market Share by Regions (2013-2018)
4.1.2 Global Anti-infective Agents Revenue and Market Share by Regions (2013-2018)
4.2 North America Anti-infective Agents Sales and Growth Rate (2013-2018)
4.3 Europe Anti-infective Agents Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Anti-infective Agents Sales and Growth Rate (2013-2018)
4.5 South America Anti-infective Agents Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Anti-infective Agents Sales and Growth Rate (2013-2018)
5 North America Anti-infective Agents by Countries
5.1 North America Anti-infective Agents Sales, Revenue and Market Share by Countries
5.1.1 North America Anti-infective Agents Sales and Market Share by Countries (2013-2018)
5.1.2 North America Anti-infective Agents Revenue and Market Share by Countries (2013-2018)
5.2 United States Anti-infective Agents Sales and Growth Rate (2013-2018)
5.3 Canada Anti-infective Agents Sales and Growth Rate (2013-2018)
5.4 Mexico Anti-infective Agents Sales and Growth Rate (2013-2018)
6 Europe Anti-infective Agents by Countries
6.1 Europe Anti-infective Agents Sales, Revenue and Market Share by Countries
6.1.1 Europe Anti-infective Agents Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Anti-infective Agents Revenue and Market Share by Countries (2013-2018)
6.2 Germany Anti-infective Agents Sales and Growth Rate (2013-2018)
6.3 UK Anti-infective Agents Sales and Growth Rate (2013-2018)
6.4 France Anti-infective Agents Sales and Growth Rate (2013-2018)
6.5 Russia Anti-infective Agents Sales and Growth Rate (2013-2018)
6.6 Italy Anti-infective Agents Sales and Growth Rate (2013-2018)
7 Asia-Pacific Anti-infective Agents by Countries
7.1 Asia-Pacific Anti-infective Agents Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anti-infective Agents Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Anti-infective Agents Revenue and Market Share by Countries (2013-2018)
7.2 China Anti-infective Agents Sales and Growth Rate (2013-2018)
7.3 Japan Anti-infective Agents Sales and Growth Rate (2013-2018)
7.4 Korea Anti-infective Agents Sales and Growth Rate (2013-2018)
7.5 India Anti-infective Agents Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Anti-infective Agents Sales and Growth Rate (2013-2018)
8 South America Anti-infective Agents by Countries
8.1 South America Anti-infective Agents Sales, Revenue and Market Share by Countries
8.1.1 South America Anti-infective Agents Sales and Market Share by Countries (2013-2018)
8.1.2 South America Anti-infective Agents Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Anti-infective Agents Sales and Growth Rate (2013-2018)
8.3 Argentina Anti-infective Agents Sales and Growth Rate (2013-2018)
8.4 Colombia Anti-infective Agents Sales and Growth Rate (2013-2018)
9 Middle East and Africa Anti-infective Agents by Countries
9.1 Middle East and Africa Anti-infective Agents Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anti-infective Agents Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Anti-infective Agents Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Anti-infective Agents Sales and Growth Rate (2013-2018)
9.3 UAE Anti-infective Agents Sales and Growth Rate (2013-2018)
9.4 Egypt Anti-infective Agents Sales and Growth Rate (2013-2018)
9.5 Nigeria Anti-infective Agents Sales and Growth Rate (2013-2018)
9.6 South Africa Anti-infective Agents Sales and Growth Rate (2013-2018)
10 Global Anti-infective Agents Market Segment by Type
10.1 Global Anti-infective Agents Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anti-infective Agents Sales and Market Share by Type (2013-2018)
10.1.2 Global Anti-infective Agents Revenue and Market Share by Type (2013-2018)
10.2 Antibacterial Drugs Sales Growth and Price
10.2.1 Global Antibacterial Drugs Sales Growth (2013-2018)
10.2.2 Global Antibacterial Drugs Price (2013-2018)
10.3 Antifungal Drugs Sales Growth and Price
10.3.1 Global Antifungal Drugs Sales Growth (2013-2018)
10.3.2 Global Antifungal Drugs Price (2013-2018)
10.4 Antiviral Drugs Sales Growth and Price
10.4.1 Global Antiviral Drugs Sales Growth (2013-2018)
10.4.2 Global Antiviral Drugs Price (2013-2018)
11 Global Anti-infective Agents Market Segment by Application
11.1 Global Anti-infective Agents Sales Market Share by Application (2013-2018)
11.2 Hospital Use Sales Growth (2013-2018)
11.3 Clinic Use Sales Growth (2013-2018)
11.4 Household Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anti-infective Agents Market Forecast (2018-2023)
12.1 Global Anti-infective Agents Sales, Revenue and Growth Rate (2018-2023)
12.2 Anti-infective Agents Market Forecast by Regions (2018-2023)
12.2.1 North America Anti-infective Agents Market Forecast (2018-2023)
12.2.2 Europe Anti-infective Agents Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anti-infective Agents Market Forecast (2018-2023)
12.2.4 South America Anti-infective Agents Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anti-infective Agents Market Forecast (2018-2023)
12.3 Anti-infective Agents Market Forecast by Type (2018-2023)
12.3.1 Global Anti-infective Agents Sales Forecast by Type (2018-2023)
12.3.2 Global Anti-infective Agents Market Share Forecast by Type (2018-2023)
12.4 Anti-infective Agents Market Forecast by Application (2018-2023)
12.4.1 Global Anti-infective Agents Sales Forecast by Application (2018-2023)
12.4.2 Global Anti-infective Agents Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anti-infective Agents Picture
Table Product Specifications of Anti-infective Agents
Figure Global Sales Market Share of Anti-infective Agents by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
